NASDAQ : AXNX

Axonex AI Group Limited — Financial statements

Healthcare · Medical Devices · Hong Kong

Last price 1 USD (Nov 2, 2026, 4:00 PM EST) · Market cap 6.36M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

Axonex AI Group Limited (AXNX) reported revenue of 2.29M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Revenue2.29M2.29M3.27M4.38M2.67M2.12M
Cost of Revenue2.04M2.04M2.54M2.82M1.41M1.50M
Gross Profit250.00K250.00K726.17K1.56M1.26M618.99K
Selling, General & Admin10.31M10.31M2.35M670.59K338.71K356.09K
Research & Development130.96K130.96K
Operating Expenses10.44M10.44M2.35M670.59K338.71K356.09K
Operating Income-10.19M-10.19M-1.63M890.79K925.07K262.90K
Interest Expense-29.39K-29.39K-34.27K-348.00
Interest & Investment Income46.88K46.88K24.88K110.0038.001.00
Other Non Operating Income (Expenses)-2.74K-2.74K1.16K21.47K54.002.51K
EBT Excluding Unusual Items-10.17M-10.17M-1.64M912.37K925.16K265.06K
Asset Writedown-137.59K-137.59K
Other Unusual Items24.49K
Pretax Income-10.31M-10.31M-1.64M912.37K949.65K265.06K
Income Tax Expense4.93K4.93K-174.62K128.93K130.22K8.48K
Earnings From Continuing Operations-10.32M-10.32M-1.46M783.44K819.42K256.58K
Minority Interest in Earnings532.00532.00
Net Income-10.31M-10.31M-1.46M783.44K819.42K256.58K
Net Income to Common-10.31M-10.31M-1.46M783.44K819.42K256.58K
Shares Outstanding (Basic)993.72K993.72K856.98K840.00K840.00K840.00K
Shares Outstanding (Diluted)993.72K993.72K856.98K840.00K840.00K840.00K
EPS (Basic)-10.38-10.38-1.700.930.980.31
EPS (Diluted)-10.38-10.38-1.700.930.980.31
Free Cash Flow-1.06M-1.06M-3.27M748.25K717.37K-185.65K
Free Cash Flow Per Share-1.07-1.07-3.810.890.85-0.22
Gross Margin10.91%10.91%22.23%35.62%47.27%29.22%
Operating Margin-444.75%-444.75%-49.83%20.32%34.60%12.41%
Profit Margin-450.30%-450.30%-44.73%17.87%30.65%12.11%
Free Cash Flow Margin-46.43%-46.43%-99.98%17.07%26.83%-8.76%
EBITDA-10.04M-10.04M-1.62M895.47K927.51K275.95K
EBITDA Margin-49.66%20.43%34.69%13.03%
D&A For EBITDA147.98K147.98K5.37K4.68K2.44K13.05K
EBIT-10.19M-10.19M-1.63M890.79K925.07K262.90K
EBIT Margin-49.83%20.32%34.60%12.41%
Effective Tax Rate14.13%13.71%3.20%

Balance sheet

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Cash & Equivalents964.14K964.14K4.52M317.32K292.94K92.65K
Short-Term Investments64.45K64.45K82.63K18.55K19.87K27.49K
Cash & Short-Term Investments1.03M1.03M4.60M335.88K312.81K120.14K
Accounts Receivable586.39K586.39K1.44M1.23M626.24K287.22K
Other Receivables1.53K
Receivables586.39K586.39K1.57M1.23M626.24K287.22K
Prepaid Expenses339.04K339.04K476.02K18.25K13.82K6.64K
Other Current Assets187.25K187.25K111.87K478.34K64.00128.00
Total Current Assets2.33M2.33M6.93M2.06M952.93K414.13K
Property, Plant & Equipment349.61K349.61K189.41K50.81K5.07K2.38K
Long-Term Investments2.50M2.50M
Other Long-Term Assets198.59K198.59K455.15K
Total Assets5.37M5.37M7.58M2.11M958.00K416.52K
Accounts Payable622.92K622.92K345.61K363.36K60.15K31.14K
Accrued Expenses325.57K325.57K173.52K240.19K66.91K10.09K
Current Portion of Long-Term Debt106.96K106.96K103.69K
Current Portion of Leases114.18K114.18K95.13K42.18K
Current Income Taxes Payable242.74K138.50K13.40K
Current Unearned Revenue39.36K39.36K4.50K20.45K28.94K
Other Current Liabilities23.48K23.48K4.83K254.40K223.22K
Total Current Liabilities1.23M1.23M722.45K913.75K548.90K277.85K
Long-Term Debt847.92K847.92K962.67K
Long-Term Leases10.16K10.16K90.97K
Other Long-Term Liabilities-1.00
Total Liabilities2.09M2.09M1.78M913.75K548.90K277.84K
Common Stock4.00K4.00K4.00K4.00K4.00K4.00K
Additional Paid-In Capital13.88M13.88M6.06M1.28K1.28K1.28K
Retained Earnings-10.58M-10.58M-269.14K1.19M408.54K137.49K
Comprehensive Income & Other-14.90K-14.90K5.08K463.00-4.72K-4.11K
Total Common Equity3.28M3.28M5.80M1.20M409.10K138.67K
Minority Interest-536.00-536.00
Shareholders' Equity3.28M3.28M5.80M1.20M409.10K138.67K
Total Liabilities & Equity5.37M5.37M7.58M2.11M958.00K416.52K
Total Debt1.08M1.08M1.25M42.18K
Net Cash (Debt)-50.62K-50.62K3.35M293.70K312.81K120.14K
Net Cash Per Share-0.05-0.053.910.350.370.14
Filing Date Shares Outstanding2.83M2.83M1.00M840.00K840.00K840.00K
Total Common Shares Outstanding1.00M1.00M1.00M840.00K840.00K840.00K
Working Capital1.09M1.09M6.21M1.15M404.04K136.29K
Book Value Per Share3.283.285.801.430.490.17
Tangible Book Value3.28M3.28M5.80M1.20M409.10K138.67K
Tangible Book Value Per Share3.283.285.801.430.490.17
Machinery124.13K124.13K22.23K14.90K6.68K1.54K
Leasehold Improvements267.86K267.86K25.72K25.82K25.82K25.82K

Cash flow statement

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Net Income-10.31M-10.31M-1.46M783.44K819.42K256.58K
Depreciation & Amortization249.36K249.36K63.38K44.57K2.44K51.50K
Asset Writedown & Restructuring Costs137.59K137.59K
Stock-Based Compensation7.93M7.93M
Provision & Write-off of Bad Debts1.98K1.98K35.35K6.33K4.53K1.16K
Other Operating Activities-532.00-532.00
Change in Accounts Receivable703.07K703.07K-234.57K-606.48K-298.23K-268.24K
Change in Accounts Payable158.03K158.03K-19.86K303.07K29.12K-4.80K
Change in Unearned Revenue35.06K35.06K-16.04K-8.58K28.94K-168.04K
Change in Income Taxes-243.76K103.83K125.26K8.48K
Change in Other Net Operating Assets255.58K255.58K-1.21M130.29K11.02K-60.74K
Operating Cash Flow-858.39K-858.39K-3.26M756.47K722.52K-184.11K
Capital Expenditures-205.05K-205.05K-7.23K-8.22K-5.14K-1.54K
Investment in Securities-2.50M-2.50M
Other Investing Activities512.57K512.57K
Investing Cash Flow-2.58M-2.58M-135.55K-8.22K-5.14K-1.54K
Short-Term Debt Issued31.72K43.97K
Long-Term Debt Issued1.16M
Total Debt Issued1.16M31.72K43.97K
Short-Term Debt Repaid-4.86K-250.39K
Long-Term Debt Repaid-103.79K-103.79K-92.26K
Total Debt Repaid-103.79K-103.79K-97.12K-250.39K
Net Debt Issued (Repaid)-103.79K-103.79K1.06M-250.39K31.72K43.97K
Issuance of Common Stock6.05M4.00K1.16K
Common Dividends Paid-548.38K
Other Financing Activities480.36K-478.42K
Financing Cash Flow-103.79K-103.79K7.59M-724.82K-516.66K45.12K
Foreign Exchange Rate Adjustments-17.01K-17.01K8.95K956.00-424.00-1.73K
Net Cash Flow-3.56M-3.56M4.20M24.39K200.28K-142.26K
Free Cash Flow-1.06M-1.06M-3.27M748.25K717.37K-185.65K
Free Cash Flow Margin-46.43%-46.43%-99.98%17.07%26.83%-8.76%
Free Cash Flow Per Share-1.07-1.07-3.810.890.85-0.22
Levered Free Cash Flow3.10M3.10M-1.93M-168.90K500.39K
Unlevered Free Cash Flow3.12M3.12M-1.91M-168.90K500.39K
Cash Interest Paid29.39K29.39K34.27K
Cash Income Tax Paid-93.65K-93.65K354.33K25.10K4.96K
Change in Working Capital1.14M1.14M-1.90M-77.87K-103.89K-493.34K

Ratios

Fiscal year April - March; amounts in USD.

TTMFY2026FY2025FY2024FY2023FY2022
Market Capitalization6.36M6.75M120.59M
Enterprise Value6.41M3.73M120.70M
Last Close Price1.066.75131.00
PS Ratio2.942.9536.92
PB Ratio0.322.0620.79
P/TBV Ratio2.052.0620.79
EV/Sales Ratio2.961.6336.95
Debt / Equity Ratio0.330.330.220.04
Debt / EBITDA Ratio0.04
Debt / FCF Ratio0.06
Net Debt / Equity Ratio0.010.01-0.58-0.24-0.77-0.87
Net Debt / EBITDA Ratio-0.01-0.012.06-0.33-0.34-0.43
Net Debt / FCF Ratio-0.05-0.051.03-0.39-0.440.65
Asset Turnover0.350.350.672.863.89
Quick Ratio1.311.318.361.711.711.47
Current Ratio1.891.899.592.251.741.49
Return on Equity (ROE)-227.11%-227.11%-41.76%97.51%299.18%
Return on Assets (ROA)-98.33%-98.33%-21.00%36.28%84.13%
Return on Invested Capital (ROIC)-305.48%-352.26%-97.08%152.93%1,390.27%1,373.15%
Return on Capital Employed (ROCE)-245.90%-245.90%-23.70%74.40%226.10%189.60%
Earnings Yield-1,037.99%-152.73%-1.21%
FCF Yield-15.78%-15.75%-2.71%
Payout Ratio66.92%
Buyback Yield / Dilution-15.96%-15.96%-2.02%